Hikma Should Face Amarin's Patent Suit, Magistrate Says
By Adam Lidgett · August 3, 2021, 8:54 PM EDT
Hikma Pharmaceuticals should not be able to dodge a lawsuit claiming it encouraged doctors to prescribe its generic version of the heart drug Vascepa for uses covered by a series of...
To view the full article, register now.